VNRX Lending Market Alert
VolitionRX Ltd (VNRX) has entered a critical zone for short sellers. As of August 27, 2026, the cost to borrow shares has spiked to 21.7% APR, indicating significant scarcity in the lending market. This borrow fee surge is accompanied by an increase in short interest, which reached 683.9K shares as of the August 14, 2026, settlement date. This represents 5% of the company's shares outstanding, a notable increase from the 3.9% reported in the previous cycle. With a days-to-cover ratio of 1.0, the stock is primed for volatility should buying pressure emerge. The combination of elevated borrow costs and rising short interest suggests that the stock is currently in a high-squeeze setup, though significant volume has yet to confirm a breakout.
Signal data sourced from CurvedTrading. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.